Non-refrigerated Ritonavir Tablet Approved in Europe and the US

摘要

The?previous capsule formulation was less heat-stable and required refrigerated storage.This will affect patients using ritonavir as a booster for other protease inhibitors.Differences in the labels for the new formulation includes new information on food. Unlike the capsule formulation, ritonavir tablets must be takenwith?meals. This is the current recommendation for all currently boosted protease inhibitors.